文献速递骨质疏松与代谢性骨病创伤骨科

血清25-羟基维生素D水平与总骨折及髋部骨折风险的关联

The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
PubMed 文献 · Osteoporos Int · 2017-02-20

该Meta分析纳入前瞻性队列研究和巢式病例对照研究,评估血清25-羟基维生素D水平与总骨折及髋部骨折风险的关联。结果显示低血清25-羟基维生素D水平与总骨折(RR 1.25,95%CI 1.06-1.43)和髋部骨折(RR 1.48,95%CI 1.29-1.68)风险升高相关;血清25-羟基维生素D水平每降低1个标准差,髋部骨折风险增加(RR 1.40,95%CI 1.20-1.61),但与总骨折风险无显著关联(RR 1.14,95%CI 0.93-1.35)。

要点

  • 低血清25-羟基维生素D水平与总骨折风险升高相关(RR 1.25,95%CI 1.06-1.43)。
  • 低血清25-羟基维生素D水平与髋部骨折风险升高相关(RR 1.48,95%CI 1.29-1.68)。
  • 血清25-羟基维生素D每降低1个标准差,髋部骨折风险增加(RR 1.40,95%CI 1.20-1.61),总骨折风险无显著关联。

核心结论

  • 研究提示低血清25-羟基维生素D水平与总骨折和髋部骨折风险升高相关。
  • 在纳入的研究中,血清25-羟基维生素D水平每降低1个标准差与髋部骨折风险相关,但与总骨折风险不相关。

研究设计与样本

  • 通过检索PubMed、EMBASE和OVID数据库(从建库至2016年6月1日)识别相关研究。
  • 纳入已发表的前瞻性队列研究或巢式病例对照研究,评估血清25-羟基维生素D水平与骨折风险的关联。
  • 共纳入16项前瞻性队列研究和3项巢式病例对照研究。
  • 由两名评价者独立提取数据,整个分析中采用相对危险度(RR)及95%置信区间(CI)。

主要发现

  • 低血清25-羟基维生素D水平与总骨折风险显著相关(RR 1.25,95%CI 1.06-1.43;I²=31.3%,异质性P=0.15)。
  • 低血清25-羟基维生素D水平与髋部骨折风险显著相关(RR 1.48,95%CI 1.29-1.68;I²=0%,异质性P=0.51)。
  • 血清25-羟基维生素D水平每降低1个标准差,髋部骨折风险增加(RR 1.40,95%CI 1.20-1.61;I²=0%,异质性P=0.51)。
  • 血清25-羟基维生素D水平每降低1个标准差与总骨折风险升高无显著关联(RR 1.14,95%CI 0.93-1.35;I²=63.2%,异质性P=0.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In this meta-analysis, we evaluated the association between serum 25-hydroxyvitamin D (25(OH) vitamin D) level and the risk of total fractures and hip fractures. Low serum 25(OH) vitamin D level is associated with an increased risk of total and hip fractures. INTRODUCTION: Data on the association between serum 25(OH) vitamin D level and the risk of fractures are conflicting. This study aimed to provide a summary of prospective cohort or nested case-control studies on the association between serum 25(OH) vitamin D level and the risk of total fractures and hip fractures. METHODS: We identified relevant studies by searching the PubMed, EMBASE, and OVID databases from their inception to June 1, 2016. We included published prospective cohort or nested case-control studies evaluating the associations of serum 25(OH) vitamin D level with the fracture risk. Two reviewers abstracted the data independently. Relative risks (RRs) with 95% confidence intervals (CIs) were derived throughout the whole analysis. RESULTS: Sixteen prospective cohort studies and three nested case-control studies were included. We found that low serum 25(OH) vitamin D level was significantly associated with the risk of total fractures (RR 1.25, 95% CI 1.06-1.43; I 2 = 31.3%, p for heterogeneity = 0.15) and hip fractures (RR 1.48, 95% CI 1.29-1.68; I 2 = 0%, p for heterogeneity = 0.51). The hip fracture risk was increased by 40% for each SD decrease in serum 25(OH) vitamin D level (RR 1.40, 95% CI 1.20-1.61; I 2 = 0%, p for heterogeneity = 0.51). The per SD decrease in serum 25(OH) vitamin D level was not associated with the increased risk of total fractures (RR 1.14, 95% CI 0.93-1.35; I 2 = 63.2%, p for heterogeneity = 0.04). CONCLUSIONS: Our study suggests that low serum 25(OH) vitamin D level is associated with increased risks of total and hip fractures. In the analyzed studies, the per SD decrease in serum 25(OH) vitamin D level was associated with the hip fracture risk but not with the total fracture risk.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Feng Y, Cheng G, Wang H, et al. The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture. Osteoporos Int. 2017. PMID: 28220196. doi:10.1007/s00198-017-3955-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。